ALK GBSC
About Us
News
Careers
Contact
Zgłaszanie działań niepożądanych
Fulltext search
Search
neffy® approved as the first needle-free anaphylaxis treatment of adults and children in Canada
Link
https://www.globenewswire.com/news-release/2026/04/15/3274254/0/en/neffy-approv…
Created date
Wed, 04/15/2026 - 12:00
Nasdaq ID
3274254
Last updated:
2026.04.15